Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Hydroxyprogesterone Caproate

Hydroxyprogesterone Caproate: A Comprehensive Overview

Introduction

Hydroxyprogesterone caproate (brand name Makena) is a synthetic form of progesterone, a hormone that plays a critical role in the menstrual cycle, pregnancy, and the development of the fetus. Hydroxyprogesterone caproate is primarily used in obstetric medicine, particularly to prevent preterm birth in women who are at risk. The medication has been a subject of interest due to its potential to reduce the risk of preterm labor in high-risk pregnancies, making it an essential treatment option for certain pregnant women.

Hydroxyprogesterone Caproate

Hydroxyprogesterone caproate is a synthetic progestin, a class of hormones that are chemically related to progesterone. It is used primarily to treat conditions related to premature labor and is administered via intramuscular injection. Hydroxyprogesterone caproate is similar to natural progesterone, but its chemical structure has been modified to increase its stability, allowing for longer-lasting effects when administered.

Chemical Properties

  • Chemical name: 17α-hydroxyprogesterone caproate

  • Molecular formula: C24H34O4

  • Mechanism of action: Hydroxyprogesterone caproate works by mimicking the effects of progesterone, helping to maintain the uterine lining and reduce the likelihood of uterine contractions that could lead to preterm birth.

Hydroxyprogesterone caproate is typically administered as an intramuscular injection and is usually given to women who are at high risk of preterm birth due to various factors. The injections are generally administered once a week from week 16 to week 37 of pregnancy.

Mechanism of Action

Hydroxyprogesterone caproate works by mimicking the effects of the natural hormone progesterone, which is essential for the maintenance of pregnancy. Progesterone helps prevent the uterine muscles from contracting prematurely and promotes the thickening of the uterine lining to allow for a successful pregnancy.

Here are some key ways in which hydroxyprogesterone caproate influences the body during pregnancy:

1. Prevents Uterine Contractions

Progesterone is a smooth muscle relaxant, and hydroxyprogesterone caproate acts similarly to prevent premature uterine contractions, which can lead to preterm labor. By decreasing the contractility of the uterus, hydroxyprogesterone helps maintain pregnancy and reduces the likelihood of premature birth.

2. Modifies the Immune Response

The body’s immune system plays a significant role in preterm birth. Inflammation can trigger early labor. Hydroxyprogesterone caproate works to modulate the immune response by reducing pro-inflammatory cytokine production, which is often involved in triggering preterm labor.

3. Supports Placental Function

The hormone helps to ensure that the placenta remains intact and continues to function properly, which is essential for providing the fetus with the necessary nutrients and oxygen. A well-functioning placenta is crucial for maintaining a full-term pregnancy.

4. Softens the Cervix

Progesterone is thought to also affect the cervix by helping it maintain its structural integrity and resist softening, which is a precursor to cervical dilation and the onset of labor.

Clinical Uses of Hydroxyprogesterone Caproate

Hydroxyprogesterone caproate is primarily used to reduce the risk of preterm birth in women who are at high risk of delivering prematurely. Preterm birth is defined as giving birth before 37 weeks of gestation, and it can lead to serious complications for both the mother and the baby. Some common medical conditions and factors that may increase a woman's risk for preterm birth include:

1. Previous Preterm Birth

Women who have had a previous preterm birth are at a significantly higher risk of having another one. Hydroxyprogesterone caproate has been shown to reduce the risk of preterm birth in women who have delivered prematurely in the past.

2. Multiple Pregnancies (Twins, Triplets)

Women carrying multiple babies are at a greater risk for preterm labor. The increased size and pressure in the uterus can cause early contractions. Hydroxyprogesterone caproate can help prevent premature birth in these women.

3. Short Cervix

A short cervix, as measured by an ultrasound, is a significant risk factor for preterm birth. If the cervix is shorter than the expected length, there is an increased likelihood that the pregnancy will end prematurely. Hydroxyprogesterone caproate can reduce the chances of preterm birth in women with this condition.

4. Risk Factors such as Age and Health Conditions

Certain health conditions, such as high blood pressure, diabetes, or infections, can increase the risk of preterm labor. Hydroxyprogesterone caproate may be considered in these cases to help maintain the pregnancy.

Administration and Dosage

Hydroxyprogesterone caproate is typically administered as an intramuscular injection. The injection is generally given once a week starting at 16-20 weeks of gestation and continuing until 37 weeks of gestation or until labor occurs, whichever comes first.

Typical Dosing Schedule:

  • Initiation: The first dose is typically given between 16 and 20 weeks of pregnancy.

  • Maintenance: The injection is given once a week for the remainder of the pregnancy.

  • Termination: The injections are discontinued at 37 weeks or earlier if labor begins.

The medication is often administered by a healthcare provider, although some women may be trained to administer the injections at home.

Efficacy of Hydroxyprogesterone Caproate

Hydroxyprogesterone caproate has been extensively studied, and several clinical trials have shown that it can significantly reduce the risk of preterm birth in women at high risk. A key study known as the 17P trial demonstrated that women with a history of preterm birth who received hydroxyprogesterone caproate were one-third less likely to experience a subsequent preterm birth. This has led to its widespread use as a preventive measure in high-risk pregnancies.

However, while hydroxyprogesterone caproate is effective in reducing the risk of preterm birth, its exact efficacy can vary depending on the population being treated, and it may not be effective for all women. Some studies have shown that it is particularly effective in reducing preterm birth rates in women with a previous history of preterm delivery, but it may be less effective for women with other risk factors.

Side Effects of Hydroxyprogesterone Caproate

Like all medications, hydroxyprogesterone caproate has potential side effects, though not everyone will experience them. The most common side effects are usually mild, and serious adverse effects are rare.

Common Side Effects

  • Injection site reactions: Pain, swelling, or redness at the site of injection.

  • Headaches: Some women may experience mild headaches as a side effect.

  • Dizziness or lightheadedness.

  • Nausea or vomiting.

  • Fatigue.

Serious Side Effects

Although rare, some more serious side effects include:

  • Thromboembolic events: Hydroxyprogesterone caproate may increase the risk of blood clots, which can lead to deep vein thrombosis (DVT), pulmonary embolism (PE), or stroke.

  • Depression or mood swings: Some women may experience changes in mood, including depression, which requires medical attention.

  • Severe allergic reactions: Symptoms such as rash, itching, difficulty breathing, or swelling of the face or throat.

Women with a history of blood clots, stroke, or liver disease should consult their doctor before starting hydroxyprogesterone caproate due to the potential risks.

Precautions and Contraindications

Before starting hydroxyprogesterone caproate, healthcare providers assess several factors to determine if the medication is appropriate for a given patient.

Contraindications

  • Allergy to the drug or any of its components.

  • History of blood clots (deep vein thrombosis, pulmonary embolism).

  • Liver disease: Hydroxyprogesterone caproate is metabolized in the liver, so it is contraindicated in patients with severe liver dysfunction.

  • Undiagnosed vaginal bleeding: The medication should not be used if a woman is experiencing abnormal bleeding, as this could be a sign of a more serious underlying issue.

  • Active or history of breast cancer or other hormone-sensitive cancers: Hydroxyprogesterone caproate may stimulate the growth of hormone-sensitive tumors.

Precautions

  • Close monitoring is necessary for women with a history of depression, hypertension, or diabetes, as these conditions may be exacerbated by the medication.

  • Routine monitoring of liver function and blood clotting may be required in some cases.

Conclusion

Hydroxyprogesterone caproate is a life-saving medication for women at high risk of preterm birth. Its ability to reduce the incidence of preterm delivery has made it an essential treatment in obstetric care, particularly for women with a history of preterm birth, multiple pregnancies, or a short cervix. While generally well-tolerated, hydroxyprogesterone caproate carries potential risks, including blood clot formation and mood changes, and requires careful monitoring throughout treatment. The decision to use this medication is based on individual risk factors and a thorough discussion between the patient and their healthcare provider.